The Role of F-FDG PET CT in Common Gynaecological Malignancies

Overview

Journal Br J Radiol

Publisher Oxford University Press

Specialty Radiology

Date 2017 Aug 24

PMID 28830238

Citations 12

Authors

Priya Narayanan

Anju Sahdev

Affiliations

Soon will be listed here.

Abstract

[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (F-FDG PET CT) has increasing clinical applications supplementing conventional TVUS, CT and MRI imaging in assessing ovarian, cervical and endometrial cancer. The published literature on the applications of F-FDG PET CT shows its use can have significant impact on patient management by improving staging of the cancers, influencing patient selection for treatment and in detecting early recurrent disease. However, the increasing clinical use of PET CT does not always align with the guidelines, recommendations or expert opinion in the use of PET CT. This article summarizes the existing evidence base for the established clinical applications and the emerging roles for F-FDG PET CT in the common gynaecological malignancies.

Citing Articles

[F]FDG PET/CT Radiomics in Cervical Cancer: A Systematic Review.

Hotton J, Beddok A, Moubtakir A, Papathanassiou D, Morland D Diagnostics (Basel). 2025; 15(1.

PMID: 39795593 PMC: 11720459. DOI: 10.3390/diagnostics15010065.

The value of combined MRI, enhanced CT and F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer.

Hong Y, Peng J, Zeng Y, Deng X, Xu W, Wang J Clin Transl Oncol. 2024; 26(12):3013-3019.

PMID: 38780807 DOI: 10.1007/s12094-024-03499-0.

Management of retroperitoneal high-grade serous carcinoma of unknown origin: A case report.

Hsieh W, Ding D World J Clin Cases. 2024; 12(6):1190-1195.

PMID: 38464925 PMC: 10921309. DOI: 10.12998/wjcc.v12.i6.1190.

Molecular image-guided surgery in gynaecological cancer: where do we stand?.

Pisano G, Wendler T, Olmos R, Garganese G, Rietbergen D, Giammarile F Eur J Nucl Med Mol Imaging. 2024; 51(10):3026-3039.

PMID: 38233609 PMC: 11300493. DOI: 10.1007/s00259-024-06604-1.

A proper protocol for routine F-FDG uEXPLORER total-body PET/CT scans.

Hu H, Huang Y, Sun H, Zhou K, Jiang L, Zhong J EJNMMI Phys. 2023; 10(1):51.

PMID: 37695324 PMC: 10495295. DOI: 10.1186/s40658-023-00573-4.

References

BORONOW R, Morrow C, Creasman W, Disaia P, Silverberg S, Miller A . Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984; 63(6):825-32. View

Kitchener H, Swart A, Qian Q, Amos C, Parmar M . Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2008; 373(9658):125-36. PMC: 2646126. DOI: 10.1016/S0140-6736(08)61766-3. View

Benedetti Panici P, Basile S, Maneschi F, Lissoni A, Signorelli M, Scambia G . Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100(23):1707-16. DOI: 10.1093/jnci/djn397. View

Sahdev A, Sohaib S, Wenaden A, Shepherd J, Reznek R . The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer. 2007; 17(3):629-36. DOI: 10.1111/j.1525-1438.2007.00829.x. View

Karlan B, Hawkins R, Hoh C, Lee M, Tse N, Cane P . Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol. 1993; 51(2):175-81. DOI: 10.1006/gyno.1993.1268. View

Lazzari R, Cecconi A, Jereczek-Fossa B, Travaini L, Dell Acqua V, Cattani F . The role of [(18)F]FDG-PET/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy. Ecancermedicalscience. 2014; 8:405. PMC: 3963705. DOI: 10.3332/ecancer.2014.409. View

Todo Y, Choi H, Kang S, Kim J, Nam J, Watari H . Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study. Gynecol Oncol. 2013; 131(2):294-8. DOI: 10.1016/j.ygyno.2013.08.008. View

Scarsbrook A, Vaidyanathan S, Chowdhury F, Swift S, Cooper R, Patel C . Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2016; 44(4):581-588. PMC: 5323466. DOI: 10.1007/s00259-016-3537-8. View

Grigsby P, Siegel B, Dehdashti F, Rader J, Zoberi I . Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004; 22(11):2167-71. DOI: 10.1200/JCO.2004.09.035. View

10.

Lee H, Ahn B, Hong C, Song B, Kim H, Kang S . Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer. Nuklearmedizin. 2011; 50(5):204-13. DOI: 10.3413/nukmed-0375-10-12. View

11.

Gu P, Pan L, Wu S, Sun L, Huang G . CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2008; 71(1):164-74. DOI: 10.1016/j.ejrad.2008.02.019. View

12.

Kyriazi S, Kaye S, deSouza N . Imaging ovarian cancer and peritoneal metastases--current and emerging techniques. Nat Rev Clin Oncol. 2010; 7(7):381-93. DOI: 10.1038/nrclinonc.2010.47. View

13.

Stehman F, Bundy B, Disaia P, Keys H, Larson J, Fowler W . Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991; 67(11):2776-85. DOI: 10.1002/1097-0142(19910601)67:11<2776::aid-cncr2820671111>3.0.co;2-l. View

14.

Dabbagh Kakhki V, Shahriari S, Treglia G, Hasanzadeh M, Zakavi S, Yousefi Z . Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature. Int J Gynecol Cancer. 2013; 23(9):1536-43. DOI: 10.1097/IGC.0000000000000003. View

15.

Schwarz J, Siegel B, Dehdashti F, Grigsby P . Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2011; 83(1):185-90. DOI: 10.1016/j.ijrobp.2011.05.053. View

16.

Fruscio R, Sina F, Dolci C, Signorelli M, Crivellaro C, DellAnna T . Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer. Gynecol Oncol. 2013; 131(3):689-93. DOI: 10.1016/j.ygyno.2013.09.024. View

17.

Wright J, Dehdashti F, Herzog T, Mutch D, Huettner P, Rader J . Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005; 104(11):2484-91. DOI: 10.1002/cncr.21527. View

18.

Schwarz J, Grigsby P, Dehdashti F, Delbeke D . The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J Nucl Med. 2009; 50 Suppl 1:64S-73S. DOI: 10.2967/jnumed.108.057257. View

19.

Risum S, Hogdall C, Loft A, Berthelsen A, Hogdall E, Nedergaard L . The diagnostic value of PET/CT for primary ovarian cancer--a prospective study. Gynecol Oncol. 2007; 105(1):145-9. DOI: 10.1016/j.ygyno.2006.11.022. View

20.

Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A . FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results. Tumori. 2015; 102(1):103-7. DOI: 10.5301/tj.5000396. View